We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Greenstick fracture

27 April 2006 By Robert Cyran

The UK joint group s revenue growth has been kneecapped by governments clamping down on costs. Once the next wave of orthopaedic products hit the market, government pricing power is likely to disappear.

This content is for Subscribers only

 

Fat opportunity

27 October 2005 By Robert Cyran

The UK orthopaedic group s shares have sunk to a twoyear low over concern that implant prices will stagnate. This is overblown. The market should see 15% sales growth for years, as an older and obese population needs more joints replaced.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)